South Africa has decided to scrap AstraZeneca’s Covid-19 vaccine roll-out plan and will instead, move ahead with Johnson and Johnson’s vaccine jabs, as per media reports.
This comes a week after the country put a hold on the vaccination drive using AstraZeneca’s vaccine, citing minimal protection against the mutated strain of the virus.
Also read: Covid-19 mutation may compel Serum Institute to make changes in vaccine composition
The country plans to sell the 1.5 million acquired doses of the vaccine and will secure the unauthorised J&J’s vaccine for inoculation.
Health Minister Zweli Mkhize said to the media that South Africa had relinquished plans to use the Oxford-AstraZeneca vaccine because it “does not prevent mild to moderate disease” caused by the variant circulating in the country.
Also read: AstraZeneca vaccine effective against Covid-19 variants: UK
The country took this decision after a study, which has not yet been peer-reviewed and did not incorporate findings of the severe cases, suggested that the AstraZeneca-Oxford vaccine provided “minimal protection” against mild disease from the variant.
“The Johnson & Johnson vaccine has been proven effective against the 501Y.V2 variant and the necessary approval processes for use in South Africa are underway,” Mkhize said, as cited in the Forbes report.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.